XML 19 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Expenses:    
Research and development $ 9,413 $ 54,011
Sales and marketing 310,000
General and administrative 191,210 1,064,283
Total operating expenses 200,623 1,428,294
Loss from operations (200,623) (1,428,294)
Finance income (expense), net 115,965 (19,374,082)
Net loss $ (84,658) $ (20,802,376)
Basic and diluted net loss per share    
Basic and diluted loss per share $ (0.00) $ (0.51)
Weighted average shares outstanding - basic and diluted 110,748,391 41,048,456